Sample size feasible [RSABE / ABEL]

posted by d_labes  – Berlin, Germany, 2012-02-08 10:47 (5254 d 05:35 ago) – Posting: # 8071
Views: 24,133

Dear AB,

if your point estimator is ok (i.e. in the range 0.95 ... 1.0526) a sample size estimation with your ISCV and a full replicate design (2-sequence-4-period) gives (using R with package PowerTOST)
library(PowerTOST)
sampleN.TOST(CV=0.47, design="2x2x4")

+++++++++++ Equivalence test - TOST +++++++++++
            Sample size estimation
-----------------------------------------------
Study design:  2x2x4 replicate crossover
log-transformed data (multiplicative model)

alpha = 0.05, target power = 0.8
BE margins        = 0.8 ... 1.25
Null (true) ratio = 0.95,  CV = 0.47

Sample size (total)
 n     power
44   0.806110


Thus the chance with a feasible sample size is greater then anticipated by my previous speaker above :cool:.

But the question remains: Why do you resist in using the 80-125% acceptance range also the EMA allows you a widening :confused:. Or is your ISCV from AUC?

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
341 visitors (0 registered, 341 guests [including 12 identified bots]).
Forum time: 17:22 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5